Patent · US Active

Pregnane steroids and their use in the treatment of CNS disorders

US8119619B2 · kind B2 · utility

3Cited by

1References

17Claims

0Family size

Assignee

UMECRINE AB · SE

Inventors

Torbjörn Bäckström · Umeå, SE
Per Lundgren · Väröbacka, SE
Ming Wang · Montgomery, US
Inga-Maj Johansson · Hagfors, SE

Key dates

Filing date	Jan 7, 2011
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Jan 7, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Steroid compounds possessing a hydrogen donor in 3beta position, either in the form of a hydroxy- or a sulfate group, function as efficient blockers of the 3alpha-hydroxy-pregnan-steroid action and thus have utility as therapeutic substances for the prevention and/or treatment of steroid related CNS disorders. Treatment methods based on the administration of these substances are disclosed, and these substances either alone or in combination are also suggested for the manufacture of pharmaceuticals for the treatment of many specific steroid induced CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.